Terlipressin versus albumin in paracentesis‐induced circulatory dysfunction in cirrhosis: A randomized study

Abstract

Terlipressin may be as effective as intravenous albumin in preventing paracentesis-induced circulatory dysfunction in patients with cirrhosis after therapeutic paracentesis.